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Abstract
Pain and sleep share mutual relations under the influence of cognitive and neuroendocrine changes. Sleep is an important 
homeostatic feature and, when impaired, contributes to the development or worsening of pain-related diseases. The aim of the 
present review is to provide a panoramic view for the generalist physician on sleep disorders that occur in pain-related diseases 
within the field of Internal Medicine, such as rheumatic diseases, acute coronary syndrome, digestive diseases, cancer, and 
headache.
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Pain and sleep influence one another. Pain may be 
exacerbated by sleep disorders (1) while sleep is impaired 
by pain (2). The concept of pain-on and pain-off neurons 
may explain the anatomical interactions of pain and sleep 
phenomena. These neurons, which are situated in the 
nucleus raphe magnus, respectively facilitate and inhibit 
nociceptive impulses to thalamocortical pathways and 
are influenced by the wake-sleep cycle: inhibitory pain-off 
nerve cells are completely activated during deep sleep 
while excitatory pain-on nerve cells are activated during 
wakefulness (3). In this context, serotonin plays a role in 
promoting both analgesia and deep sleep (4).
Neuroendocrine and autonomic mechanisms may 
influence and be influenced by pain and sleep. Concern-
ing chronic widespread pain syndromes, sleep disorders 
and nociceptive afference are important to elevate the 
sympathetic tonus, which my lead to vascular remodeling, 
muscular atrophy and fatigue (5).
Pain and sleep disturbances may generate or perpetuate 
cognitive, affective and motivational dysfunctions, which, 
in turn, promote hypervigilance and frequent awakenings. 
This is explained by the sharing of common afferent circuits 
such as the parabrachial-amygdala and parabrachial-
hypothalamic pathways (6).
Less than 6 h of sleep may contribute to pain manifes-
tations the following day (7). Similarly, sleep deprivation, 
especially of deep sleep, results in wakening unrefreshed 
with widespread pain and fatigue in healthy sedentary 
individuals. In this context, alpha wave (8-10 Hz) activity 
inappropriately intrudes during delta wave (0.5-3.5 Hz) 
activity (8-10).
The restoration of adequate sleep is essential to avoid 
exacerbation of painful symptoms (11). In the case of REM 
sleep deprivation, a reduced pain threshold persists for a 
variable period of time, even after normal sleep has been 
restored (12).
Rheumatic diseases
Sleep disorders have been described in more than 
75% of subjects suffering from various forms of rheumatic 
diseases and fatigue is observed in up to 98% of cases 
(13). Modifications of pain mediators, such as serotonin 
and substance P, and of neuroimmune mechanisms, such 
as inflammatory cytokines (interleukin-1 and tumor necrosis 
factor-α, TNF-α) and cell-mediated immunity have been also 
described. Moreover, there is the involvement of neuroen-
docrine mechanisms, such as the hypothalamic-pituitary-
adrenal axis and the thyroid, alongside the autonomic 
nervous system (13).
In general, there is reduced sleep efficiency accompa-
nied by increased periods of wakefulness during the night. 
Sleep is typically superficial and disrupted and primary sleep 
disorders are frequent in these conditions, such as periodic 
limb movements and sleep apnea (14). 
Pain, sleep disturbance and depression are predictors 
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of the severe fatigue that occurs in rheumatoid arthritis, 
osteoarthritis, and fibromyalgia (15). The relationship be-
tween pain and sleep disorders in rheumatic diseases has 
been observed not only in fibromyalgia (16) and rheumatoid 
arthritis (15), but also in low back pain (17), osteoarthritis 
(18), ankylosing spondylitis (19), Sjögren’s syndrome (20), 
systemic lupus erythematosus (21), systemic sclerosis (22), 
and soft-tissue disorders (23).
Fibromyalgia
The importance of non-restorative sleep, which affects 
more than 90% of patients, is such that this manifestation 
is now included among the new diagnostic criteria (24). 
The non-restorative sleep and increased wake time after 
sleep onset act as predictors of pain and fatigue and have 
social implications, even when anxiety and depression are 
excluded (25).
An electroencephalographic pattern of alpha wave 
intrusion in delta wave sleep (alpha-delta sleep) has been 
described in fibromyalgia (16), but also in other chronic 
widespread pain conditions, and even in healthy individuals. 
The phasic alpha-delta pattern, in which the distribution of 
alpha activity overlaps the delta activity, especially during 
slow-wave sleep (26), suggests that there is a disturbance 
in fibromyalgia sleep homeostasis mediated by pain stimuli 
that lead to awakening (27); however, studies have included 
a small sample size of patients. Other authors focused on 
the cyclic alternating pattern of non-REM sleep to explain 
the relationship of altered sleep and pain perception (28) 
and some controversial studies have reported reduction in 
total sleep time and in sleep efficiency and modification of 
sleep stage distribution, with a predominance of light sleep 
compared to deep sleep, instead of sleep instability (29).
Changes in heart rate variability have also been de-
scribed in patients with fibromyalgia, reflecting sympathetic 
hyperactivity in contrast to hyporesponsiveness against 
sympathetic stimulation, or during sleep (30).
A higher prevalence of upper airway resistance syn-
drome in patients with fibromyalgia (31) may not reflect a 
direct relationship between the two conditions, since mus-
culoskeletal pain may be attributed to restricted physical 
activity in obstructive sleep apnea (32). 
The approval of Pregabaline, a derivative of γ-aminobutyric 
acid (GABA) that has analgesic, anticonvulsant, anxiolytic, 
and sleep-modulating activities, has been a real advance 
for the management of non-restorative sleep in fibromyalgia 
(33), and odium oxybate, a metabolite of dopamine, which 
increases GABA, has recently been proposed to increase 
slow-wave sleep and decrease sleep disruption (34).
Osteoarthritis
Clinical symptoms of osteoarthritis tend to be exacer-
bated at night and on awakening. The involvement of the 
lumbar spine (17), knee or hip (18) can impair sleep onset 
and maintenance. The findings of sleep fragmentation due 
to increased number of arousals (35) and periodic limb 
movements (36) may explain fatigue and joint stiffness (of 
less than 30 min) upon awakening, which are frequently 
reported by the patients.
Soft tissue disorders
Sleep studies are only available for carpal tunnel 
syndrome. Patients may complain of nocturnal and early 
morning awakenings with hand pain and numbness. Non-
restorative sleep, daytime sleepiness and polysonographic 
findings such as arousals and periodic limb movement 
indexes tend to improve after surgical treatment of the 
affected wrist (23). However, carpal tunnel syndrome may 
be the presenting symptom of underlying diabetes mellitus, 
hypothyroidism or connective tissue disease, which are also 
associated with sleep disorders.
Many investigators have tried to explain why tendonitis, 
tenosynovitis, bursitis, and periarthritis tend to worsen at 
night, as described for shoulder-related disorders, but the 
reasons are still unclear and deserve more study (37).
Ankylosing spondylitis
Up to 80% of patients with ankylosing spondylitis tend 
to wake during the night in need of walking in order to get 
some relief of low back pain. Polysomnography shows 
increased sleep latency and fragmented sleep (19), which 
can be the result of functional, often motor, disabilities. 
Fatigue is a prominent symptom of ankylosing spondylitis, 
reported by more than half the patients, and is associated 
with functional disability (38). Also, patients complain about 
excessive daytime sleepiness and the frequent need for 
naps (39). Arthritis, costochondral inflammation and en-
thesitis gradually lead to spine ankylosis and chest wall 
rigidity and obstructive sleep apnea, when present, further 
aggravates the respiratory condition of the patients (40). 
Anti-TNF agents improve both sleep disorders and inflam-
matory activity and shed light on the pathophysiology of 
the disease (41).
Rheumatoid arthritis
Morning stiffness differs from osteoarthritis because 
in rheumatoid arthritis it lasts more than 1 h and in os-
teoarthritis, less than 30 min (42). Additionally, association 
between clinical manifestations of the disease and fatigue, 
excessive daytime sleepiness and sleep alterations has 
been reported (43). Decreased sleep efficiency, superficial 
sleep, reduction in REM sleep, and an increase in the num-
ber of arousals (44) may exacerbate sleep fragmentation 
and fatigue, as well as periodic limb movements (45) and 
sleep apnea (46). Skeletal abnormalities, particularly of 
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the temporomandibular joint and the cervical spine may 
underlie sleep apnea in rheumatoid arthritis (47). As reported 
in ankylosing spondylitis, improvement of the sleep apnea 
and the fatigue following administration of TNF-α blockers 
has been demonstrated (48).
Sjögren’s syndrome
Prominent fatigue is very commonly reported by pa-
tients and is related to sleep disorders, musculoskeletal 
pain, anxiety (49), and fibromyalgia, which occurs in 55% 
of the patients (50). Polysomnographic findings reflect the 
non-restorative sleep condition reported by the patients, 
with reduction in sleep efficiency, intermediate awaken-
ings (20) and rhythmic oral movements attributed to the 
lack of saliva (51).
Systemic lupus erythematosus
Besides prominent fatigue that is the hallmark of rheu-
matic diseases with a remarkable autoimmune component 
(21), and polysomnography findings of increased sleep 
latency and reduced total sleep time, not related to depres-
sion (52), co-morbidities play an important role in pain and 
sleep interactions in systemic lupus erythematosus. Obesity, 
neuropsychiatric and kidney involvement and the use of 
medications such as antihistamines and glucocorticoids 
may act as confounders when restless legs syndrome (53) 
and sleep apnea (54) are present.
Scleroderma
Fatigue and poor sleep are also frequent complaints 
in scleroderma (55). In addition, sleep disturbances may 
aggravate the manifestations of the disease. The presence 
of sleep apnea may contribute to endothelial damage, 
particularly in the lungs, periodic limb movements may ag-
gravate nocturnal pain due to ischemia and the presence of 
gastroesophageal reflux may contribute to the fragmentation 
of sleep and fatigue (22).
Coronary heart disease
Among the changes in sleep architecture in acute 
coronary syndromes, the most frequent are difficulty of 
initiating and maintaining sleep, the presence of arousals 
and reduced total sleep time. It has been hypothesized that 
both quantity and quality of sleep have a negative influence 
on patient recovery (56). Superficial and disrupted sleep is 
described in 60% of patients with coronary artery disease 
and is compared to the hypervigilance observed in post-
traumatic stress disorder (57).
Sleep disorders in patients with coronary artery diseases 
may aggravate myocardial ischemia. Given that cytokines 
modulate sleep, an immune substrate has been considered 
to explain insomnia and parasomnias, such as nightmares, 
which may precede an acute coronary syndrome. Moreover, 
hypoxemia due to obstructive sleep apnea, when present, 
promotes the deterioration of cardiac ischemia (58).
Digestive tract diseases
Irritable bowel syndrome
Complaints of abdominal cramps and flatulence persist 
during the night, awakening the patient. Sleep fragmentation 
leads to poor sleep, which, in turn, promotes deterioration of 
intestinal symptoms (59). In addition, patients have altered 
perception of their sleep, considering that it has not been 
established that sleep latency or efficiency are altered in 
irritable bowel syndrome (60). Autonomic dysfunction, in 
terms of increased sympathetic tonus during REM sleep, 
may underlie the relationship between disease activity and 
sleep fragmentation (61).
Gastroesophageal reflux disease
Although the frequency of gastroesophageal reflux is 
highest during wakefulness, its presence during sleep has 
a greater impact on the quality of life of the patients. This 
is because night reflux lasts longer and saliva production 
is reduced. In addition to the sleep fragmentation and early 
awakening, gastroesophageal reflux causes respiratory 
symptoms such as coughing and wheezing. Aspiration of 
gastric acid reflux into the larynx is common in individuals 
with asthma (62). The stimulation of vagal nerve afferents 
in the distal esophagus by the presence of gastric acid 
reflux supports the treatment of the disease when present 
in asthma patients. Lifestyle modifications and eating light 
meals at night at least 2 h before bedtime, are advised even 
when there is indication for surgery. Additionally, raising 
the head of the bed and sleeping in left lateral position are 
recommended in order to reduce esophageal acid exposure 
and to increase esophageal clearance of gastric contents. 
The association of proton pump inhibitors helps improve 
sleep quality (63).
Neoplastic diseases
The combination of pain, fatigue and sleep disturbances 
is reported by more than 40% of cancer patients (64). Pain 
occurs in 59% of individuals under treatment for cancer 
and 64% of those with advanced disease (65). Fatigue 
affects most patients, especially after surgical procedures, 
chemotherapy, immunotherapy and radiotherapy. Fatigue, 
excessive sleepiness and restless legs syndrome may all 
be associated with anemia and iron deficiency and occur 
particularly in lung, breast, genitourinary, gastrointestinal, 
and non-melanoma skin cancer (66). 
Besides fragmented and superficial sleep, reported in 
up to 72% of the cases (67), screening for the presence of 
sleep apnea is appropriate in patients with oral or oropharynx 
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cancer before and after treatment (68). 
Treatment of insomnia may improve fatigue and even 
immunity in cancer patients. However, sedatives and sleep 
inducers may result in lack of attention or drowsiness during 
the day, which could enhance fatigue and muscle pain and 
reduce the pain threshold (69). Moreover, pain killers and 
steroids may aggravate the symptoms of fatigue, increase 
daytime sleep and worsen non-restorative sleep (70), and 
opioids may contribute to the emergence of central apnea 
during sleep (71). In addition, side effects of chemotherapy, 
pain, nausea, diarrhea, and urinary urgency facilitate sleep 
fragmentation (68). Such interruptions invariably result in 
insufficient rest and increased fatigue. It is worth noting the 
value of behavioral psychological intervention that improves 
sleep quality and cancer-related fatigue (72).
Headaches
There is a strong interface between sleep disorders and 
headaches. Even though a causal link between the two 
conditions has not yet been established, improvement in 
sleep quality results in improvement of headache, especially 
in cases of sleep deprivation (73).
The relationship between sleep-wake cycle and the vari-
ous types of headaches, such as migraine, cluster headache 
and paroxysmal hemicrania, is due to the activation of the 
posterior hypothalamus. Brain stem and diencephalon 
pathways in headaches are related to sleep fragmentation, 
as also described for visceral pain (74).
Sleep disorders are found in patients with morning or 
night occurring migraine. The circadian periodicity in morn-
ing migraine is related to REM sleep and glucocorticoids 
and catecholamine cycles (73). Night migraine, in turn, may 
involve alterations in the regulatory mechanisms of awaken-
ings during sleep. Crises tend to be preceded by episodes 
of yawning. Despite the fragmented sleep during periods of 
crises, fewer awakenings have been described in the night 
preceding the night migraine episodes (75).
Cluster headaches tend to predominate in the early 
morning hours and 90 min after sleep onset. The substrate 
of their association with REM sleep is secretion of melatonin 
and cortisol (76). Paroxysmal hemicrania also has a certain 
relation to REM sleep (77). In contrast, hypnic headache 
tends to awaken the patient in the first half of the night for 
at least 15 nights a month. Interestingly, treatment of sleep 
fragmentation tends to improve chronic migraine, tension 
headache, cluster headache, and hypnic headache pain 
intensity (78). Insomnia and nonrestorative sleep have 
been recognized as risk factors for chronification of tension 
headache, migraine and medication overuse headache 
(79) and restoration of sleep quality, in turn, reverses the 
condition (80).
A possible link between primary headaches and narco-
lepsy has been proposed to be due to a higher frequency of 
migraine in patients with narcolepsy, especially in women, 
which may experience episodes of narcolepsy prior to the 
migrainous attacks (81). The polymorphism of receptor-2 of 
the gene encoding orexin/hypocretin, which is involved in 
the sleep-wake cycle in narcolepsy and in pain modulation, 
has been described in individuals with cluster headaches 
(82). It is, therefore, evident that the damage of lateral 
hypothalamic orexinergic neurons affects the activation of 
REM-off neurons that disrupt REM sleep. These neurons 
in the ventrolateral periaqueductal gray substance are 
also involved in the reduction of nociceptive activity in the 
trigeminal and caudate nucleus and their inhibition favors 
pain mechanisms (81).
The correlation between severity of migraine and the 
presence of restless legs syndrome may demonstrate that 
migraine may also have a substrate of dopaminergic impair-
ment (83), iron metabolism imbalance (84) and depression 
(85), as occurs in restless legs syndrome.
In morning and night migraine, 30-70% of patients have 
obstructive sleep apnea or intense snoring (86). Cluster 
headache and paroxysmal hemicranic headache, particu-
larly in its chronic form, are also more frequent in subjects 
with obstructive sleep apnea than in the general popula-
tion (87). Conversely, 15-74% of patients with obstructive 
sleep apnea wake up with headache, and in 48% of cases 
the headache pattern cannot be classified (88). Nocturnal 
awakenings accompanied by intense headache crises in 
individuals with obstructive sleep apnea have been associ-
ated with intracranial hypertension (89).
Possible pathophysiological bases for the association 
between headache and sleep apnea are hypoxemia and 
hypercapnia, since symptoms improved after treatment with 
continuous positive airway pressure (CPAP) or supplemen-
tal oxygen (88). Morning migraine related to sleep apnea is 
more prevalent in women with moderate to severe apnea 
and in subjects with a history of primary headache, and 
tends to improve with the use of CPAP (90). Likewise, the 
benefit of CPAP is observed in cluster headaches triggered 
by oxyhemoglobin desaturation, especially during REM 
sleep (87).
Conclusion
The generalist physician should be aware of the contribu-
tion of sleep to the initiation or worsening of diseases that 
have pain as a prominent manifestation. Further reviews 
are warranted to discuss the pathophysiology underlying 
such association. 
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